Literature DB >> 25836985

Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma.

Manal M Hassan1, Reham Abdel-Wahab2, Ahmed Kaseb3, Ahmed Shalaby3, Alexandria T Phan4, Hashem B El-Serag5, Ernest Hawk6, Jeff Morris7, Kanwal Pratap Singh Raghav3, Ju-Seog Lee8, Jean-Nicolas Vauthey9, Gehan Bortus3, Harrys A Torres10, Christopher I Amos11, Robert A Wolff3, Donghui Li3.   

Abstract

BACKGROUND & AIMS: Despite the significant association between obesity and several cancers, it has been difficult to establish an association between obesity and hepatocellular carcinoma (HCC). Patients with HCC often have ascites, making it a challenge to determine body mass index (BMI) accurately, and many factors contribute to the development of HCC. We performed a case-control study to investigate whether obesity early in adulthood affects risk, age of onset, or outcomes of patients with HCC.
METHODS: We interviewed 622 patients newly diagnosed with HCC from January 2004 through December 2013, along with 660 healthy controls (frequency-matched by age and sex) to determine weights, heights, and body sizes (self-reported) at various ages before HCC development or enrollment as controls. Multivariable logistic and Cox regression analyses were performed to determine the independent effects of early obesity on risk for HCC and patient outcomes, respectively. BMI was calculated, and patients with a BMI of 30 kg/m(2) or greater were considered obese.
RESULTS: Obesity in early adulthood (age, mid-20s to mid-40s) is a significant risk factor for HCC. The estimated odds ratios were 2.6 (95% confidence interval [CI], 1.4-4.4), 2.3 (95% CI, 1.2-4.4), and 3.6 (95% CI, 1.5-8.9) for the entire population, for men, and for women, respectively. Each unit increase in BMI at early adulthood was associated with a 3.89-month decrease in age at HCC diagnosis (P < .001). Moreover, there was a synergistic interaction between obesity and hepatitis virus infection. However, we found no effect of obesity on the overall survival of patients with HCC.
CONCLUSIONS: Early adulthood obesity is associated with an increased risk of developing HCC at a young age in the absence of major HCC risk factors, with no effect on outcomes of patients with HCC.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Case-Control; HCC; Obesity; Risk Factor

Mesh:

Year:  2015        PMID: 25836985      PMCID: PMC4778392          DOI: 10.1053/j.gastro.2015.03.044

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  62 in total

1.  The estimation of synergy or antagonism.

Authors:  K J Rothman
Journal:  Am J Epidemiol       Date:  1976-05       Impact factor: 4.897

2.  Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.

Authors:  Ahmed O Kaseb; Jeffrey S Morris; Manal M Hassan; Adnan M Siddiqui; E Lin; Lianchun Xiao; Eddie K Abdalla; Jean-Nicolas Vauthey; Thomas A Aloia; Sunil Krishnan; James L Abbruzzese
Journal:  J Clin Oncol       Date:  2011-09-12       Impact factor: 44.544

3.  Safety of liver resections in obese and overweight patients.

Authors:  Silvio Balzan; Ganesh Nagarajan; Olivier Farges; Claudio Zettler Galleano; Safi Dokmak; Catherine Paugam; Jacques Belghiti
Journal:  World J Surg       Date:  2010-12       Impact factor: 3.352

4.  Host- and disease-specific factors affecting steatosis in chronic hepatitis C.

Authors:  A J Czaja; H A Carpenter; P J Santrach; S B Moore
Journal:  J Hepatol       Date:  1998-08       Impact factor: 25.083

5.  Accuracy of patients' reports of comorbid disease and their association with mortality in ESRD.

Authors:  Kerri L Cavanaugh; Sharon Stein Merkin; Laura C Plantinga; Nancy E Fink; John H Sadler; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2008-04-02       Impact factor: 8.860

Review 6.  Alcohol, cofactors and the genetics of hepatocellular carcinoma.

Authors:  Mimi C Yu; Jian-Min Yuan; Shelly C Lu
Journal:  J Gastroenterol Hepatol       Date:  2008-03       Impact factor: 4.029

Review 7.  The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence.

Authors:  Hashem B El-Serag; Howard Hampel; Fariba Javadi
Journal:  Clin Gastroenterol Hepatol       Date:  2006-03       Impact factor: 11.382

8.  Systemic therapy for hepatocellular carcinoma.

Authors:  Melanie B Thomas
Journal:  Cancer J       Date:  2008 Mar-Apr       Impact factor: 3.360

9.  Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.

Authors:  Ryosuke Tateishi; Takeshi Okanoue; Naoto Fujiwara; Kiwamu Okita; Kendo Kiyosawa; Masao Omata; Hiromitsu Kumada; Norio Hayashi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2014-06-15       Impact factor: 7.527

10.  Incidence of hepatocellular carcinoma in Texas Latinos, 1995-2010: an update.

Authors:  Amelie G Ramirez; Edgar Munoz; Alan E C Holden; Rebecca T Adeigbe; Lucina Suarez
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

View more
  37 in total

1.  Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic.

Authors:  Iliana Doycheva; Kymberly D Watt; Ghassoub Rifai; Rachel Abou Mrad; Rocio Lopez; Nizar N Zein; William D Carey; Naim Alkhouri
Journal:  Dig Dis Sci       Date:  2017-02-13       Impact factor: 3.199

Review 2.  Nonalcoholic fatty liver disease and hepatocellular carcinoma.

Authors:  Stephanie Klein; Jean-François Dufour
Journal:  Hepat Oncol       Date:  2017-10-30

3.  Obesity: Childhood obesity: time bomb for future burden of chronic liver disease.

Authors:  Milena Marietti; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-27       Impact factor: 46.802

4.  Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.

Authors:  Neehar D Parikh; Sherry Fu; Huiying Rao; Ming Yang; Yumeng Li; Corey Powell; Elizabeth Wu; Andy Lin; Baocai Xing; Lai Wei; Anna S F Lok
Journal:  Dig Dis Sci       Date:  2017-09-25       Impact factor: 3.199

5.  Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma.

Authors:  Saleh A Alqahtani; Faisal M Sanai; Ashwaq Alolayan; Faisal Abaalkhail; Hamad Alsuhaibani; Mazen Hassanain; Waleed Alhazzani; Abdullah Alsuhaibani; Abdullah Algarni; Alejandro Forner; Richard S Finn; Waleed K Al-Hamoudi
Journal:  Saudi J Gastroenterol       Date:  2020-10       Impact factor: 2.485

6.  Diabetes is associated with increased risk of hepatocellular carcinoma in non-alcoholic steatohepatitis with cirrhosis-implications for surveillance and future pharmacotherapy.

Authors:  Michael P Johnston; Janisha Patel; Christopher D Byrne
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

7.  Indian Hedgehog links obesity to development of hepatocellular carcinoma.

Authors:  Yong Chun Chong; Tau En Lim; Yanyun Fu; Eun Myoung Shin; Vinay Tergaonkar; Weiping Han
Journal:  Oncogene       Date:  2018-11-23       Impact factor: 9.867

Review 8.  Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.

Authors:  Amit G Singal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-15       Impact factor: 11.382

9.  Sex and Ethnic Differences in the Association of Obesity With Risk of Hepatocellular Carcinoma.

Authors:  Veronica Wendy Setiawan; Unhee Lim; Loren Lipworth; Shelly C Lu; John Shepherd; Thomas Ernst; Lynne R Wilkens; Brian E Henderson; Loïc Le Marchand
Journal:  Clin Gastroenterol Hepatol       Date:  2015-09-25       Impact factor: 11.382

Review 10.  Hepatitis C and insulin action: An intimate relationship.

Authors:  Hilla Knobler; Stephen Malnick
Journal:  World J Hepatol       Date:  2016-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.